Rational targets for design and synthesis of anti-HIV agents.
Pearson
M L
ML
D000998:Antiviral Agents / Q000494:pharmacology*; D015195:Drug Design; D006678:HIV / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D016325:HIV Long Terminal Repeat; D017320:HIV Protease Inhibitors; D006801:Humans; D018894:Reverse Transcriptase Inhibitors; D015533:Transcriptional Activation
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors